SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.

PubWeight™: 2.67‹?› | Rank: Top 1%

🔗 View Article (PMID 32211820)

Published in JAMA Oncol on March 25, 2020

Authors

Jing Yu1,2,3, Wen Ouyang1,2,3, Melvin L K Chua1,4,5, Conghua Xie1,2,3

Author Affiliations

1: Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.
2: Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.
3: Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.
4: Division of Radiation Oncology, Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
5: Oncology Academic Programme, Duke-NUS Medical School, Singapore.

Associated clinical trials:

Registry on NEN Patients and COVID-19 | NCT04444401